BioSpace News Archive

Biotech Bay

Personalis Launches Early Access Program for Cell-Free DNA ACE Exome for Tumor Neoantigens

The company also stated that the program will be offered exclusively to its immuno-oncology partners.

November 16, 2017
·
2 min read
MindBytes BVBA Initiates Oncology R&D Program Focused on Patient Empowerment and is Selected as One of Five Finalists for Astellas Oncology C3 Prize

MindBytes believes these tools can empower patients and play an important role in addressing ongoing challenges in cancer care.

November 16, 2017
·
4 min read
BioMidwest

Titan Spine Announces the First Endoskeleton Interbody Fusion Cases in Australia

Surgeries open entry into new market and expand global footprint.

November 16, 2017
·
3 min read
Business

Teijin Pharma and SRETT Sign Exclusive Distribution Agreement for Respiratory Remote-Monitoring Device

Teijin Pharmaand SRETT announced today they have agreed to an exclusive distribution arrangement in Japan for TeleOx, a device developed by SRETT which remotely monitors patient’s respiratory functions　in oxygen therapy.

November 16, 2017
·
3 min read
Policy

Recce Ltd. U.S. FDA Grants Qualified Infectious Disease Product Designation for RECCE 327

This designation is an important achievement in the regulatory path for RECCE 327 with the FDA and has significant benefits to the business.

November 16, 2017
·
2 min read
Business

Nephron Pharma Continues Efforts to Solve Drug Shortage Crisis by Increasing Production and Expanding Capacity

Nephron officials recognize that persistent drug shortages pose a threat to the quality of patient care as discussed in the ASHP letter entitled “Healthcare Groups Urge Congressional Action on Drug Shortages.”

November 16, 2017
·
2 min read
BioMidwest

Zomedica Pharmaceuticals Expects Trading of its Common Shares on the NYSE American to Commence on November 21, 2017

Zomedica will retain its listing on the TSX Venture Exchange (TSX-V).

November 16, 2017
·
5 min read
BioMidwest

ARCA Biopharma Announces Issuance of European Patent for Treating Cardiovascular Diseases and Conditions With a New Chemical Entity Utilizing Genetic Targeting

The European patent, entitled “Methods and Compositions for Cardiovascular Diseases and Conditions,” provides protection for this novel approach to treating patients with cardiovascular disease and conditions.

November 16, 2017
·
5 min read
Biotech Beach

Cytori Reports Bioequivalence Trial Results in Ovarian Cancer at AAPS

The data was presented this week at the American Association of Pharmaceutical Scientists Annual Meeting held in San Diego and the abstract is available online.

November 16, 2017
·
4 min read